Clinical Trial Update: Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation

View source ↗

Summary

An update on the efficacy of crizotinib in patients with ALK-translocated non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Crizotinib (crizotinib)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Non-small Cell Lung Cancer(NSCLC) | Status: UNKNOWN